Amit Khandhar

Company: HDT Bio

Job title: Director - Formulations

Seminars:

Developing Safe & Effective Delivery Technologies for Self-Amplifying RNA Vaccines & Therapeutics 9:30 am

Discussing HDT bio’s LION™ delivery technology – a cationic nanocarrier that is structurally and functionally distinct from LNPs Leveraging LION for enabling self-amplifying RNA encoded mAb therapies Thermostable formulations of self-amplifying RNA vaccines New CompanyRead more

day: Conference Day Two

Deep-Dive Workshop: Accomplishing Improved Encapsulation & Targeting of RNA Therapeutics by Uncovering Innovative Delivery Strategies for More Potent & Effective Therapies 11:00 am

A major bottleneck inhibiting the full potential of all RNA therapeutics is delivery. With self-amplifying and circular RNA payloads typically being larger than those of linear mRNA, this complicates their encapsulation. Furthermore, while current lipid nanoparticles (LNPs) have demonstrated safety and efficacy of mRNA vaccines, their use has been restricted to intramuscular administration. During this…Read more

day: Conference Day Two